QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wegmüller, R. Articles by Hurrell, R. F. Search for Related Content PubMed PubMed Citation Articles by Wegmüller, R. Articles by Hurrell, R. F.

---

Nutrient Metabolism

Particle Size Reduction and Encapsulation Affect the Bioavailability of Ferric Pyrophosphate in Rats¹

Human Nutrition Laboratory, Institute of Food Science and Nutrition and ^* Physiology and Animal Husbandry, Institute of Animal Sciences, Swiss Federal Institute of Technology, Zürich, Switzerland

²To whom correspondence should be addressed. E-mail: rita.wegmueller{at}ilw.agrl.ethz.ch.

Particle size is an important determinant of Fe absorption from poorly soluble Fe compounds in foods. Decreasing the particle size of elemental iron powders increases their absorption. The effect of a reduction in particle size on the bioavailability of ferric pyrophosphate (FePP) is unclear. Encapsulation of iron compounds for food fortification may protect against adverse sensory changes, but at the same time may reduce bioavailability. The hemoglobin (Hb) repletion method in weanling Sprague-Dawley rats (n = 100) was used to compare the relative bioavailability (RBV) of 4 forms of FePP: 1) regular FePP [mean particle size (MPS) 21 µm]; 2) MPS 2.5 µm; 3) MPS 2.5 µm encapsulated in hydrogenated palm oil; and 4) MPS 0.5 µm with emulsifiers. The RBV compared with ferrous sulfate was calculated by the slope-ratio technique. The RBV was 43% for encapsulated MPS 2.5 µm, significantly lower than the other FePP compounds (P < 0.05), 59% for the regular FePP, and 69% for MPS 2.5 µm, not different from each other but significantly lower than ferrous sulfate (P < 0.05), and 95% for emulsified MPS 0.5 µm, comparable to ferrous sulfate. Encapsulation of FePP with hydrogenated palm oil at a capsule:substrate ratio of 60:40 decreased RBV. Particle size reduction increases the RBV of FePP and may make this compound more useful for food fortification.

KEY WORDS: • ferric pyrophosphate • iron • bioavailability • particle size • encapsulation

This article has been cited by other articles:

				F. Rohner, F. O. Ernst, M. Arnold, M. Hilbe, R. Biebinger, F. Ehrensperger, S. E. Pratsinis, W. Langhans, R. F. Hurrell, and M. B. Zimmermann Synthesis, Characterization, and Bioavailability in Rats of Ferric Phosphate Nanoparticles J. Nutr., March 1, 2007; 137(3): 614 - 619. [Abstract] [Full Text] [PDF]

				D. Perez-Conesa, G. Lopez, and G. Ros Effect of Probiotic, Prebiotic and Synbiotic Follow-up Infant Formulas on Iron Bioavailability in Rats Food Science and Technology International, February 1, 2007; 13(1): 69 - 77. [Abstract] [PDF]

				D. Moretti, M. B Zimmermann, S. Muthayya, P. Thankachan, T.-C. Lee, A. V Kurpad, and R. F Hurrell Extruded rice fortified with micronized ground ferric pyrophosphate reduces iron deficiency in Indian schoolchildren: a double-blind randomized controlled trial. Am. J. Clinical Nutrition, October 1, 2006; 84(4): 822 - 829. [Abstract] [Full Text] [PDF]

				R. Wegmuller, F. Camara, M. B. Zimmermann, P. Adou, and R. F. Hurrell Salt Dual-Fortified with Iodine and Micronized Ground Ferric Pyrophosphate Affects Iron Status but Not Hemoglobin in Children in Cote d'Ivoire J. Nutr., July 1, 2006; 136(7): 1814 - 1820. [Abstract] [Full Text] [PDF]